v3.26.1
Consolidated Statements of Operations and Other Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenues    
Total Revenues $ 131 $ 144
Cost of revenues 0 5
Research and development expenses 4,189 5,025
Selling, general, and administrative expenses 7,429 7,730
Total costs and expenses 11,618 12,760
Loss from Operations (11,487) (12,616)
Other Income (Expense)    
Loss on issuance of common stock (2,703) 0
Gain on investment in equity securities 94 0
Gain on sale of asset 0 10,000
Interest income 267 140
Interest expense (12) (10)
Total Other Income (Expense) (2,354) 10,130
Income Tax Expense (2) (2)
Net Loss (13,843) (2,488)
Comprehensive Loss $ (13,843) $ (2,488)
Net loss per common share basic $ (5.35) $ (1.7)
Net loss per common share diluted $ (5.35) $ (1.7)
Weighted average shares used in computing net loss per common share basic 2,588,327 1,463,609
Weighted average shares used in computing net loss per common share diluted 2,588,327 1,463,609
Royalty Revenue [Member]    
Revenues    
Total Revenues $ 131 $ 119
Product Revenue [Member]    
Revenues    
Total Revenues $ 0 $ 25